Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Pulmonary Medicine|July 12, 2021
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort studyYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.Scientific Reports|September 18, 2021
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosisYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.Thorax|March 31, 2022
Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosisHyogo Naoi, Yuzo Suzuki, Kazutaka Mori, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2024
CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β SignalingHyogo Naoi, Yuzo Suzuki, Asuka Miyagi, et al.BMC Pulmonary Medicine|October 27, 2022
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseasesNoriyuki Enomoto, Hyogo Naoi, Yasutaka Mochizuka, et al.Chest|November 7, 2024
Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based AnalysisHironao Hozumi, Yoshinari Endo, Masato Kono, et al.Scientific Reports|July 19, 2025
Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumoniaNoriyuki Enomoto, Masayuki Watanuki, Shogo Nakai, et al.Respiratory Medicine|February 26, 2024
Radiological and histopathological features and treatment response by subtypes of interstitial pneumonia with autoimmune features: A prospective, multicentre cohort studyNoriyuki Enomoto, Shusuke Yazawa, Yasutaka Mochizuka, et al.Scientific Reports|October 13, 2025
Risk stratification of acute exacerbations by autoantibodies in patients with idiopathic interstitial pneumoniaShusuke Yazawa, Noriyuki Enomoto, Shogo Nakai, et al.Respiratory Research|September 28, 2024
CXCL10 predicts autoimmune features and a favorable clinical course in patients with IIP: post hoc analysis of a prospective and multicenter cohort studyNoriyuki Enomoto, Shogo Nakai, Shusuke Yazawa, et al.Pageof 2